Page 5 - Klingenstein Fields News Today

Klingenstein Fields & Co. LP decreased its position in Medtronic plc (NYSE:MDT – Free Report) by 0.8% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 198,608 shares of the medical technology company’s stock after selling 1,665 shares during the period. Klingenstein Fields & Co. […]

Klingenstein Fields & Co. LP lifted its stake in Roper Technologies, Inc. (NYSE:ROP – Free Report) by 0.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 36,233 shares of the industrial products company’s stock after acquiring an additional 68 […]

Klingenstein Fields & Co. LP reduced its stake in Lockheed Martin Co. (NYSE:LMT – Free Report) by 11.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 6,993 shares of the aerospace company’s stock after selling 915 shares during the quarter. Klingenstein Fields & […]

Klingenstein Fields & Co. LP decreased its position in United Parcel Service, Inc. (NYSE:UPS – Free Report) by 0.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 155,649 shares of the transportation company’s stock after selling 1,354 shares during the quarter. […]

Klingenstein Fields & Co. LP reduced its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 3.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 22,052 shares of the biopharmaceutical company’s stock after selling 730 shares during the period. […]

Klingenstein Fields & Co. LP reduced its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 2.8% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 322,140 shares of the biopharmaceutical company’s stock after selling 9,340 shares during the period. Klingenstein Fields & Co. LP’s holdings in Pfizer were worth $9,274,000 […]

Klingenstein Fields & Co. LP cut its position in The Procter & Gamble Company (NYSE:PG – Free Report) by 1.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 42,066 shares of the company’s stock after selling 461 shares during the quarter. Klingenstein Fields […]

Klingenstein Fields & Co. LP lowered its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 129,255 shares of the healthcare product maker’s stock after selling 2,415 shares during the period. Klingenstein Fields & […]

Klingenstein Fields & Co. LP decreased its stake in shares of Fortive Co. (NYSE:FTV – Free Report) by 1.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 294,027 shares of the technology company’s stock after selling 3,732 shares during the quarter. […]

Klingenstein Fields & Co. LP reduced its stake in Medtronic plc (NYSE:MDT – Free Report) by 0.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 198,608 shares of the medical technology company’s stock after selling 1,665 shares during the […]